Skip to main content
Full access
Clinical Synthesis
Published Online: 1 April 2012

Antipsychotic Medication Nonadherence: Risk Factors and Remedies

Abstract

Understanding determinants of antipsychotic medication adherence is critical as nonadherence plays a significant role in psychotic relapse and each relapse contributes to accrued social toxicity and disability. “Insight” or lack thereof and a negative medication attitude are critical variables that have repeatedly been shown to be risk factors for nonadherence.

Abstract

Understanding determinants of antipsychotic medication adherence is critical as nonadherence plays a significant role in psychotic relapse and each relapse contributes to accrued social toxicity and disability. “Insight” or lack thereof and a negative medication attitude are critical variables that have repeatedly been shown to be risk factors for nonadherence. We examine how those risk factors can lead to nonadherence and describe evidence-based interventions to improve nonadherence. We also discuss newer approaches adapted from other branches of medicine that have shown some promise in increasing adherence to antipsychotics, specifically directly-observed-therapy (DOT) and providing financial incentives. Adherence-improving interventions need to be deployed in a stepped-up manner of increasing intensity and tailored to the specific etiologies of nonadherence.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

History

Published online: 1 April 2012
Published in print: Spring 2012

Authors

Affiliations

Oliver Freudenreich, M.D.

Notes

Address correspondence to Oliver Freudenreich, M.D., Erich Lindemann Mental Health Center, Freedom Trail Clinic, 25 Staniford Street, Boston, MA 02114; e-mail: [email protected]

Funding Information

Author Information and CME Disclosure
Oliver Freudenreich, M.D., Department of Psychiatry, Massachusetts General Hospital, and Harvard Medical School, Boston, MA
Dr. Freudenreich reports Consultant: Beacon Health Strategies, Transcept; Research Grant: Pfizer, Honorarium: Reed Medical Education
Corinne Cather, Ph.D., Department of Psychiatry, Massachusetts General Hospital, and Harvard Medical School, Boston, MA
Dr. Cather reports no competing interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Focus

PPV Articles - Focus

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share